RecruitingNCT02998788
Risk Evaluation and Management in Heart Failure
Sponsor
Ruijin Hospital
Enrollment
1,000 participants
Start Date
Jun 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- aged 18 and above
- inpatient with one of the following clinical situations:
- congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
- cardiogenic shock
- Insufficient high output cardiac
- with impaired cardiac function diagnosed by echocardiography
- able to provide informed consent
Exclusion Criteria1
- expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02998788
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations